CN105833143A - Chinese medicinal composition for treating respiratory diseases and preparation method thereof - Google Patents
Chinese medicinal composition for treating respiratory diseases and preparation method thereof Download PDFInfo
- Publication number
- CN105833143A CN105833143A CN201610425347.XA CN201610425347A CN105833143A CN 105833143 A CN105833143 A CN 105833143A CN 201610425347 A CN201610425347 A CN 201610425347A CN 105833143 A CN105833143 A CN 105833143A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix stemonae
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating respiratory diseases and a preparation method thereof, and belongs to the field of traditional Chinese medicine treatment of the respiratory diseases. The invention firstly discloses the Chinese medicinal composition for treating the respiratory diseases, which comprises the following components: common andrographis herb, sessile stemona root, Chinese paris rhizome and almond. On the basis of the Chinese medicinal composition disclosed by the invention, raw material medicines of drynaria and cape jasmine fruit are further added, so that the Chinese medicinal composition has better effects of clearing heat and removing toxicity and relieving cough and asthma. A comparison result of a clinical curative effect proves that an obvious synergistic effect is taken between common andrographis herb, sessile stemona root, Chinese paris rhizome and almond and rhizoma drynaria as well as cape jasmine fruit, and a cure rate and a total effective rate of treatment of the respiratory diseases can be obviously improved. The Chinese medicinal composition disclosed by the invention is reasonable in compatibility, has no toxic or side effects, has an exact curative effect, and can be used for preparing a medicament for treating the respiratory diseases.
Description
Technical field
The present invention relates to treat the Chinese medicine composition of respiratory tract disease, further relate to described Chinese medicine composition
Preparation method, belongs to the treatment by Chinese herbs field of respiratory tract disease.
Background technology
Respiratory tract disease, including upper and lower respiratory tract Acute and chronic inflammation, allergic airway disease disease
Sick etc., wherein acute respiratory infection is most commonly seen.Common respiratory tract disease has flu, bronchus
Inflammation, pneumonia, tonsillitis etc., harm human body is healthy, patient's nasal obstruction, watery nasal discharge, dyspnea,
Sound of speaking is sent out mute, cough etc., brings many miseries to patient.
Treat the Western medicine of respiratory tract disease at present, though rapid-action, but generally there is bigger side effect,
Gastrointestinal tract is had bigger stimulation；Onset is slow, the course for the treatment of to use treatment by Chinese herbs the most mostly to exist
The defects such as longer, curative effect is undesirable.
Therefore, develop and a kind of respiratory tract disease is had definite therapeutic effect, rapid-action pure Chinese medicine system
Agent, will have important application prospect.
Summary of the invention
The technical problem to be solved is to provide a kind of Chinese medicine composition treating respiratory tract disease
Thing, this Chinese medicine composition includes that to respiratory tract disease the treatment total effective rate of flu, pneumonia etc. is high, treats
Effect is definite；
Another technical problem to be solved by this invention is to provide the system of a kind of described Chinese medicine composition
Preparation Method.
For solving above-mentioned technical problem, the technical solution used in the present invention is:
First the present invention discloses a kind of Chinese medicine composition treating respiratory tract disease, including following group
Point: Herba Andrographis, the Radix Stemonae, Rhizoma Paridis and Semen Armeniacae Amarum；The weight portion of each component is: Herba Andrographis 20-40 part,
Radix Stemonae 20-30 part, Rhizoma Paridis 10-20 part, Semen Armeniacae Amarum 5-20 part；Preferably, the weight portion of each component is:
Herba Andrographis 30 parts, the Radix Stemonae 21 parts, Rhizoma Paridis 15 parts, 7 parts of Semen Armeniacae Amarum.
Herba Andrographis, for acanthaceous plant Herba Andrographis (circular cone palpus medicinal herbs) Andrographis paniculata
(Burm.f.) dry aerial parts of Nees.Nature and flavor are bitter, cold.GUIXIN, lung, large intestine, wing
Guang warp.Function cures mainly: heat-clearing and toxic substances removing, removing heat from blood, detumescence.For cold, fever, laryngopharynx swelling and pain, mouth
The raw skin ulcer of tongue, pertussis chronic cough, dysentery, the puckery pain of pyretic stranguria, carbuncle skin infection, venom.
The Radix Stemonae, for Stemonaceae plant Radix Stemonae Stemona sessilifolia (Miq.) Miq.,
Radix stemonae japonicae Stemona japonica (Bl.) Miq. or radix stemonae tuberosae Stemona tuberosa Lour.
Dried root.Nature and flavor are sweet, bitter, tepor.Return lung meridian.Slightly poisonous.Function cures mainly: nourishing the lung to keep the adverse QI downward
Cough-relieving, parasite killing.Cough for new chronic cough, pulmonary tuberculosis cough, pertussis；Outer for head louse, body louse, pinworm
Parasitosis, pudendal pruritus.Honey Radix Stemonae nourishing the lung to arrest cough.For deficiency of YIN chronic cough.
Rhizoma Paridis, for the rhizome of liliaceous plant Rhizoma Paridis, RHIZOMA PARIDIS and several congeners thereof.
Nature and flavor toil, cold, poisonous.Enter the heart, Liver Channel.Function cures mainly: heat-clearing and toxic substances removing, and antiasthmatic-antitussive puts out
Wind is calmed the frightened.Control carbuncle, furuncle, scrofula, sore throat, chronic tracheitis, infantile convulsion tic, snakeworm
Bite.
Semen Armeniacae Amarum, for the dry seed of the bitter in the mouth such as rosaceous plant Fructus Pruni or Prunus armeniaca L.var.ansu Maxim..Nature and flavor are bitter, temperature, poisonous.
Enter lung, large intestine channel.Function cures mainly: expelling phlegm for arresting cough, relievings asthma, intestine moistening.Control exogenous cough, dyspnea with fullness of the chest,
Sore throat, dryness of the intestine constipation.
The Chinese medicine composition that the present invention is prepared by Herba Andrographis, the Radix Stemonae, Rhizoma Paridis and Semen Armeniacae Amarum is to respiratory tract disease
There is certain curative effect.When adding following crude drug on the basis of drug composition in the present invention, have
Preferably heat-clearing and toxic substances removing, effect of relieving cough and asthma: Rhizoma Drynariae and son；Rhizoma Drynariae 20-30 part,
Sub-10-25 part；Preferably, the weight portion of each component is: Rhizoma Drynariae 25 parts, son 20 parts.
Rhizoma Drynariae, for Plants of Polypodiaceae Mongolian oak Herba pteridii latiusculi Drynaria fortunei (Kunze) J.Sm.'s
Dry rhizome.Nature and flavor are bitter, temperature.Return kidney, Liver Channel.Function cures mainly: the kidney invigorating bone strengthening, continues and hinders pain relieving.
For lumbago due to renal deficiency, Hiccough and deaf, odontoseisis, falling winks frustrates, injured bone；External treatment alopecia areata,
Vitiligo.
Fructus Gardeniae, for the dry mature fruit of Maguireothamnus speciosus Fructus Gardeniae Gardenia jasminoides Ellis.
Nature and flavor are bitter, cold.GUIXIN, lung, tri-jiao channel.Function cures mainly: pathogenic fire purging relieving restlessness, clearing away heat and promoting diuresis, removing heat from blood
Removing toxic substances.Vexed for calentura, jaundice dark coloured urine, blood strangury and dry pain, heat in blood tells nosebleed, conjunctival congestion and swelling pain, fire-toxin
Skin infection；External treatment bruise pain.
The comparative result of clinical efficacy shows, the present invention is prepared by Herba Andrographis, the Radix Stemonae, Rhizoma Paridis and Semen Armeniacae Amarum
Chinese medicine composition to flu have certain therapeutic effect, the cure rate treated 3 days is 60%, effectively
Rate is 12%, and total effective rate reaches 72%.And enter on the basis of Herba Andrographis, the Radix Stemonae, Rhizoma Paridis and Semen Armeniacae Amarum
One step adds Rhizoma Drynariae and son, and cure rate and the total effective rate for the treatment of flu significantly improve, cure rate
Reaching 90%, total effective rate reaches 100%, and its cure rate and total effective rate are than adding other crude drug components
Do not improve 20 percentage points and more than 18 percentage points.Result above proves, crude drug Herba Andrographis,
There is between the Radix Stemonae, Rhizoma Paridis, Semen Armeniacae Amarum and Rhizoma Drynariae, son obvious synergistic function.
When adding following crude drug further on the basis of the above-mentioned Chinese medicine composition of the present invention, have more preferably
Effect of heat-clearing and toxic substances removing: Flos Lonicerae and Herba Taraxaci；The weight portion of each component is: Herba Taraxaci 10-35
Part, Flos Lonicerae 15-25 part；Preferably, the weight portion of each component is: Herba Taraxaci 30 parts, gold silver
Spend 20 parts.
Flos Lonicerae, for caprifoliaceae plant Radix Ophiopogonis Lonicera japonica Thunb., Flos Lonicerae
Lonicera hypoglauca Miq., Flos Lonicerae (hair calyx Radix Ophiopogonis) Lonicera confusa DC. or hair
The flower that the dry flower of style Radix Ophiopogonis Lonicera dasystyla Rehd. or band are just opened.Nature and flavor are sweet, cold.
Return lung, the heart, stomach warp.Function cures mainly: heat-clearing and toxic substances removing, wind-heat dissipating.For carbuncle furuncle, sore throat,
Erysipelas, toxic-heat and blood stasis, anemopyretic cold, epidemic febrile disease is generated heat.
Herba Taraxaci, for feverfew Herba Taraxaci Taraxacum mongolicum Hand.-Mazz., alkali
Ground Herba Taraxaci Taraxacum sinicum Kitag. or belong to the dry herb of several plants together.Nature and flavor hardship,
Sweet, cold.Return liver, stomach warp.Function cures mainly: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, inducing diuresis for treating stranguria syndrome.For
Furuncle swelling toxin, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, lung abscess, acute appendicitis, jaundice due to damp-heat, the puckery pain of pyretic stranguria.
Patients with pneumonia take the present invention by Herba Andrographis, the Radix Stemonae, Rhizoma Paridis, Semen Armeniacae Amarum, Rhizoma Drynariae, son,
Chinese medicine composition prepared by Flos Lonicerae and Herba Taraxaci, the cure rate treated 7 days reaches 97.3%, the most effectively
Rate reaches 100%, determined curative effect.
The present invention further discloses the preparation method of a kind of above-mentioned Chinese medicine composition, including following step
Rapid: to weigh each component according to described weight portion, pulverize, mix homogeneously, to obtain final product.The present invention is to described
Pulverizing is not particularly limited, and can be adjusted as required, as reference, is crushed to 100-300
Mesh.
On the basis of the present invention treats the Chinese medicine composition of respiratory tract disease, add suitable adjuvant or load
Body can prepare the medicine for the treatment of respiratory tract disease.Wherein, the dosage form of described medicine includes: powder,
Tablet, pill, granule, soft capsule, hard capsule or microcapsule.
Described carrier or adjuvant refer to the conventional carrier of pharmaceutical field or adjuvant, such as: diluent, collapse
Split agent, lubricant, excipient, binding agent, fluidizer, filler, surfactant etc.；It addition,
Other adjuvant such as flavouring agent and sweeting agent can also be added in the composition.Described diluent can be
One or more increase tablet weight and compositions of volume, conventional diluent include lactose, starch,
Pregelatinized Starch, microcrystalline Cellulose, sorbitol, mannitol and inorganic calcium salt etc.；Most common of which
For lactose, starch, microcrystalline Cellulose.Described disintegrating agent can be crospolyvinylpyrrolidone (with
Gross weight ratio is for 2-6%), cross-linking sodium carboxymethyl cellulose (with gross weight ratio for 2-6%), sea
In alginic acid (with gross weight than for 2-5%), microcrystalline Cellulose (with gross weight than for 5-15%) it
One or more mixture；Wherein with crospolyvinylpyrrolidone (with gross weight ratio as 2-7%),
Cross-linking sodium carboxymethyl cellulose (with gross weight than for 2-6%) is preferred.Described lubricant includes firmly
Fat acid, sodium stearate, magnesium stearate, calcium stearate, Polyethylene Glycol, Pulvis Talci, hydrogenated vegetable oil
One of plant or several mixture；Wherein most widely suited with magnesium stearate.The amount ranges of lubricant (with
Gross weight ratio) it is 0.10-1%, general consumption is 0.25-0.75%, and optimum amount is 0.5-0.7%.
Described binding agent can be one or more compositions being conducive to pelletizing；It can be starch slurry
(10-30%, with binding agent gross weight ratio), and hydroxypropyl methyl cellulose (2-5%, total with binding agent
Weight ratio), polyvinylpyrrolidone (2-20%, with binding agent gross weight ratio), with polyvinylpyrrolidine
The ethanol water of ketone is preferred.Described fluidizer can be in micropowder silica gel, Pulvis Talci, magnesium trisilicate
One or more mixture.Described surfactant can be that one or more can improve wettability
With increase drug-eluting composition, commonly use for sodium lauryl sulphate (usual range is 0.2-6%,
With gross weight ratio).
Each taste crude drug used by the present invention can be commercially available at pharmacy.
The usage of Chinese medicine composition of the present invention and consumption: the dosage of the present invention depend on concrete dosage form,
The factors such as the age of patient, health status.As guidance: usage and dosage: powder, it is administered orally 3 every time
To 5 grams, 2 times on the one, 3 days be a course for the treatment of.
Technical solution of the present invention compared with prior art, has the advantages that
The compatibility of Chinese medicine composition of the present invention is reasonable, crude drug Herba Andrographis, the Radix Stemonae, Rhizoma Paridis, Semen Armeniacae Amarum with
There is obvious synergistic function, it is possible to significantly improve respiratory tract disease and control between Rhizoma Drynariae, son
The cure rate treated and total effective rate.The determined curative effect of Chinese medicine composition of the present invention, has no side effect, system
Preparation Method is simple, has a good application prospect.
Detailed description of the invention
Further describing the present invention, advantages of the present invention and feature below in conjunction with specific embodiment will
Apparent along with description.It should be understood that described embodiment is only exemplary, not to the present invention
Scope constitute any restriction.It will be understood by those skilled in the art that without departing from the present invention's
The details of technical solution of the present invention and form can be modified or replace under spirit and scope, but this
A little amendments or replacement each fall within protection scope of the present invention.
Embodiment 1 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 20, the Radix Stemonae 20, Rhizoma Paridis 10, Fructus Pruni according to following ratio
Core 5；It is crushed to 100 mesh, mix homogeneously, to obtain final product.
Embodiment 2 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 40, the Radix Stemonae 30, Rhizoma Paridis 20, Fructus Pruni according to following ratio
Core 20；It is crushed to 300 mesh, mix homogeneously, to obtain final product.
Embodiment 3 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 30, the Radix Stemonae 21, Rhizoma Paridis 15, Fructus Pruni according to following ratio
Core 7；It is crushed to 200 mesh, mix homogeneously, to obtain final product.
Embodiment 4 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 20, the Radix Stemonae 20, Rhizoma Paridis 10, Fructus Pruni according to following ratio
Core 5, Rhizoma Drynariae 20, son 10；It is crushed to 100 mesh, mix homogeneously, to obtain final product.
Embodiment 5 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 40, the Radix Stemonae 30, Rhizoma Paridis 20, Fructus Pruni according to following ratio
Core 20, Rhizoma Drynariae 30, son 25；It is crushed to 300 mesh, mix homogeneously, to obtain final product.
Embodiment 6 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 30, the Radix Stemonae 21, Rhizoma Paridis 15, Fructus Pruni according to following ratio
Core 7, Rhizoma Drynariae 25, son 20；It is crushed to 200 mesh, mix homogeneously, to obtain final product.
Embodiment 7 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 20, the Radix Stemonae 20, Rhizoma Paridis 10, Fructus Pruni according to following ratio
Core 5, Rhizoma Drynariae 20, son 10, Herba Taraxaci 10, Flos Lonicerae 15；It is crushed to 100 mesh, mixing
Uniformly, to obtain final product.
Embodiment 8 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 40, the Radix Stemonae 30, Rhizoma Paridis 20, Fructus Pruni according to following ratio
Core 20, Rhizoma Drynariae 30, son 25, Herba Taraxaci 35, Flos Lonicerae 25；It is crushed to 300 mesh, mixed
Close uniformly, to obtain final product.
Embodiment 9 Chinese medicine composition
Each component (g) is weighed: Herba Andrographis 30, the Radix Stemonae 21, Rhizoma Paridis 15, Fructus Pruni according to following ratio
Core 7, Rhizoma Drynariae 25, son 20, Herba Taraxaci 30, Flos Lonicerae 20；It is crushed to 200 mesh, mixing
Uniformly, to obtain final product.
The preparation of embodiment 10 tablet
Example 6 preparation Chinese medicine composition 15g add starch 15g, mix homogeneously, then with dextrin
30g mix homogeneously, adds ethanol (50%) soft material the most processed；Pelletized by 16 mesh nylon mesh, at 60 DEG C
Being dried, dry granular, after 16 mesh sieve granulate, adds magnesium stearate 5 grams, tabletting after mix homogeneously.
The preparation of embodiment 11 soft capsule
By glycerol 200g, gelatin 320g, pure water 450g, pigment 2g mix homogeneously post-heating dissolve,
Vacuum defoamation, standing insulation, obtaining glue glue；Chinese medicine composition 60g embodiment 9 prepared adds
Mix with change glue glue after heat of solution and roll pelletization according to soft capsule Zhanang technique, through ball of shaping, wash, do
Dry, pick up ball, obtain soft capsule.
The effect observation of test example 1 traditional Chinese medicine composition for treating flu
By cold patients 400 example, cardinal symptom is nasal obstruction, watery nasal discharge, sneeze, dry cough, pharyngeal discomfort
With pharyngalgia etc., be randomly divided into 8 groups (each group patient in terms of sex, age and the state of an illness difference without statistics
Learn meaning (P > 0.05), there is comparability), use following Chinese medicine composition 1-8 (unit: g) respectively:
Chinese medicine composition 1: Herba Andrographis 30, the Radix Stemonae 21, Rhizoma Paridis 15, Semen Armeniacae Amarum 7；
Chinese medicine composition 2-8 adds following crude drug respectively on the basis of Chinese medicine composition 1:
Chinese medicine composition 2: Rhizoma Drynariae 25, Radix Platycodonis 20；
Chinese medicine composition 3: Rhizoma Drynariae 25, Herba Houttuyniae 20；
Chinese medicine composition 4: Rhizoma Drynariae 25, son 20；
Chinese medicine composition 5: the Radix Astragali 25, son 20；
Chinese medicine composition 6: Radix Bupleuri 25, son 20；
Chinese medicine composition 7: Fructus Forsythiae 25, Radix Isatidis 20；
Chinese medicine composition 8: Radix Scutellariae 25, Radix Sophorae Flavescentis 20.
The preparation method of each Chinese medicine composition with embodiment 6, using method is: boiled water is taken after mixing it with water, every day
Taking twice, each 3g, treatment 3d is 1 course for the treatment of, adds up curative effect after terminating 1 course for the treatment of.
Efficacy assessment standard:
Recovery from illness: malaise symptoms all disappears；
Effective: malaise symptoms partial disappearance or alleviation；
Invalid: malaise symptoms, without alleviating, even increases the weight of.
The comparative result of clinical efficacy is shown in Table 1.Total effective rate/%=cure rate+effective percentage.
The effect of table 1 different traditional Chinese medicine composition for treating flu
Result shows, Chinese medicine composition 1 of the present invention has certain therapeutic effect to flu, treats one
Fully recover the course for the treatment of 30 people, and cure rate is 60%；Effective 6 people, effective percentage is 12%；Invalid 14 people,
Inefficiency is 28%；Total effective rate reaches 72%.And use Chinese medicine composition 4 of the present invention, cold patients
Fully recover 45 people, and cure rate is 90%；Effective 5 people, effective percentage is 10%, and total effective rate reaches 100%；
Its cure rate and total effective rate, apparently higher than other Chinese medicine compositions, have been respectively increased 20 percentage points
With more than 18 percentage points.Observing in the treatment, all there is not serious adverse reaction in each group.
Result above proves, adds osteomiosis on the basis of crude drug Herba Andrographis, the Radix Stemonae, Rhizoma Paridis, Semen Armeniacae Amarum
Benefit, son, it is possible to significantly improve cure rate and the total effective rate for the treatment of flu.Illustrate, Herba Andrographis,
There is between the Radix Stemonae, Rhizoma Paridis, Semen Armeniacae Amarum and Rhizoma Drynariae, son obvious synergistic function.
Test example 2 traditional Chinese medicine composition for treating pneumonia
It is pneumonia (cardinal symptom is heating, cough, expectoration, accompanies dyspnea) by clinical diagnosis
Patient 37 people, takes the Chinese medicine composition of the embodiment of the present invention 9, and boiled water is taken after mixing it with water, twice daily,
3g every time, the cure rate treated 7 days is 97.3%, and total effective rate is 100%.
Claims (10)
1. the Chinese medicine composition treating respiratory tract disease, it is characterised in that include following component:
Herba Andrographis, the Radix Stemonae, Rhizoma Paridis and Semen Armeniacae Amarum.
2. according to the Chinese medicine composition described in claim 1, it is characterised in that the weight portion of each component
For: Herba Andrographis 20-40 part, Radix Stemonae 20-30 part, Rhizoma Paridis 10-20 part, Semen Armeniacae Amarum 5-20 part；
Preferably, the weight portion of each component is: Herba Andrographis 30 parts, the Radix Stemonae 21 parts, Rhizoma Paridis 15 parts,
7 parts of Semen Armeniacae Amarum.
3. the Chinese medicine composition treating respiratory tract disease, it is characterised in that include following component:
Herba Andrographis, the Radix Stemonae, Rhizoma Paridis, Semen Armeniacae Amarum, Rhizoma Drynariae and son.
4. according to the Chinese medicine composition described in claim 3, it is characterised in that the weight portion of each component
For: Herba Andrographis 20-40 part, Radix Stemonae 20-30 part, Rhizoma Paridis 10-20 part, Semen Armeniacae Amarum 5-20 part, osteomiosis
Mend 20-30 part, sub-10-25 part；
Preferably, the weight portion of each component is: Herba Andrographis 30 parts, the Radix Stemonae 21 parts, Rhizoma Paridis 15 parts,
7 parts of Semen Armeniacae Amarum, Rhizoma Drynariae 25 parts, son 20 parts.
5. the Chinese medicine composition treating respiratory tract disease, it is characterised in that include following component:
Herba Andrographis, the Radix Stemonae, Rhizoma Paridis, Semen Armeniacae Amarum, Rhizoma Drynariae, son, Flos Lonicerae and Herba Taraxaci.
6. according to the Chinese medicine composition described in claim 5, it is characterised in that the weight portion of each component
For: Herba Andrographis 20-40 part, Radix Stemonae 20-30 part, Rhizoma Paridis 10-20 part, Semen Armeniacae Amarum 5-20 part, osteomiosis
Mend 20-30 part, sub-10-25 part, Herba Taraxaci 10-35 part, Flos Lonicerae 15-25 part；
Preferably, the weight portion of each component is: Herba Andrographis 30 parts, the Radix Stemonae 21 parts, Rhizoma Paridis 15 parts,
7 parts of Semen Armeniacae Amarum, Rhizoma Drynariae 25 parts, son 20 parts, Herba Taraxaci 30 parts, Flos Lonicerae 20 parts.
7. a preparation method for Chinese medicine composition described in claim 1 to 6 any one, its feature
It is, comprises the following steps: weigh each component according to described weight portion, pulverize, mix homogeneously, i.e.
?.
8. the Chinese medicine composition described in claim 1 to 6 any one is in preparation treatment respiratory tract disease
Medicine in purposes.
9. according to the purposes described in claim 8, it is characterised in that the dosage form of described medicine includes:
Powder, tablet, pill, granule, soft capsule, hard capsule or microcapsule.
10. according to the purposes described in claim 8, it is characterised in that described respiratory tract disease includes:
Flu, tracheitis, bronchitis or pneumonia.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610425347.XA CN105833143A (en) | 2016-06-13 | 2016-06-13 | Chinese medicinal composition for treating respiratory diseases and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610425347.XA CN105833143A (en) | 2016-06-13 | 2016-06-13 | Chinese medicinal composition for treating respiratory diseases and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105833143A true CN105833143A (en) | 2016-08-10 |
Family
ID=56576859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610425347.XA Pending CN105833143A (en) | 2016-06-13 | 2016-06-13 | Chinese medicinal composition for treating respiratory diseases and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105833143A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101411804A (en) * | 2007-10-19 | 2009-04-22 | 鞍山钢铁集团公司 | Mixture for clearing lung-heat and preparation method thereof |
| CN101543602A (en) * | 2008-03-28 | 2009-09-30 | 天科仁祥技术（北京）有限责任公司 | Chinese medicinal composition for treating upper respiratory tract infection and preparation method thereof |
| CN102579588A (en) * | 2012-03-28 | 2012-07-18 | 张继成 | Heat clearing and exterior syndrome relieving capsule |
-
2016
- 2016-06-13 CN CN201610425347.XA patent/CN105833143A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101411804A (en) * | 2007-10-19 | 2009-04-22 | 鞍山钢铁集团公司 | Mixture for clearing lung-heat and preparation method thereof |
| CN101543602A (en) * | 2008-03-28 | 2009-09-30 | 天科仁祥技术（北京）有限责任公司 | Chinese medicinal composition for treating upper respiratory tract infection and preparation method thereof |
| CN102579588A (en) * | 2012-03-28 | 2012-07-18 | 张继成 | Heat clearing and exterior syndrome relieving capsule |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101787432B1 (en) | Method for manufacturing oriental medicine composition which improves menorrhagia and dysmenorrhea comprising fermented velvet antler and yeast hydrolysate | |
| CN103169903B (en) | Traditional Chinese medicine preparation for treating child bronchitis and preparation method thereof | |
| CN104187172B (en) | Functional feed for treating enterogastritis diseases of turtles and preparation method of functional feed | |
| CN101829293A (en) | Traditional Chinese medicine composite for treating cough disease and preparation method thereof | |
| CN105012392A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN111317798A (en) | Traditional Chinese medicine composition for detoxifying, eliminating dampness and relieving sore throat and application thereof | |
| CN103007012B (en) | Traditional Chinese medicine composition for treating toothaches and preparation method thereof | |
| CN104147572A (en) | Cold and fever wind-dispelling and heat-dispersing preparation and preparation method | |
| CN105233116A (en) | Traditional Chinese medicine composition for preventing and controlling respiratory tract infection of chicken and preparation method thereof | |
| CN104147574A (en) | Heat-clearing and exterior-releasing traditional Chinese medicine composition for treating cold and fever and preparation method thereof | |
| CN104173977A (en) | Traditional Chinese medicine composition for stopping rhinorrhea, clearing heat and relieving fidgetiness in common cold and preparation method of traditional Chinese medicine composition | |
| CN104706976A (en) | Traditional Chinese medicine preparation capable of benefiting qi for tranquillization to treatinsomnia and preparation method of traditional Chinese medicine preparation | |
| CN103301385A (en) | Traditional Chinese medicine composition for treating animal diarrhea and preparation method thereof | |
| CN103656291B (en) | Medicine for treating pharyngitis and preparation method thereof | |
| CN103611005B (en) | Medicine for treating chronic pharyngitis and preparation method thereof | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN112168947A (en) | Traditional Chinese medicine composition for treating pneumonia and preparation method thereof | |
| CN105381291A (en) | Traditional Chinese medicine composition for preventing and treating pneumonia, preparation method and applications thereof | |
| CN105833143A (en) | Chinese medicinal composition for treating respiratory diseases and preparation method thereof | |
| CN108815329A (en) | A kind of Chinese medicine composition and preparation method thereof for treating flu | |
| CN102772645B (en) | Traditional Chinese medicine for treating cold and preparation method thereof | |
| CN104667247A (en) | Traditional Chinese medicinal composition for treating cough and preparation method of traditional Chinese medicinal composition | |
| CN105687873A (en) | Preparation for treating nasal polyp, and preparation method of preparation | |
| CN105535096A (en) | Traditional Chinese medicine composition for treating suppurative otitis meadia as well as preparation method and application thereof | |
| CN105796992A (en) | Oral liquid for effective treatment of oral ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160810 |